bf/NASDAQ:CRSP_icon.jpeg

COM:CRISPRTX

CRISPR Therapeutics AG

  • Stock

Last Close

46.29

22/11 21:00

Market Cap

4.72B

Beta: -

Volume Today

1.50M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.00
-
0.01
866.20%
0.15
909.28%
0.01
95.77%
0.27
4,149.44%
0.00
99.89%
0.33
111,598.82%
0.00
99.94%
0.17
85,275.69%
cash conversion cycle
-90.80
-
90.40
199.55%
cash per share
0.03
-
5.32
16,403.81%
25.74
383.55%
5.99
76.75%
9.52
59.06%
17.35
82.25%
25.63
47.72%
31.33
22.22%
23.35
25.46%
21.38
8.44%
company equity multiplier
-0.21
-
-5.48
2,453.65%
1.48
127.04%
1.44
2.49%
1.25
13.69%
1.14
8.93%
1.10
3.27%
1.15
4.41%
1.20
4.28%
1.18
0.99%
days of inventory outstanding
days of payables outstanding
90.80
-
106.90
17.72%
days of sales outstanding
500.95
-
223.14
55.46%
23.38
89.52%
10.28
56.02%
0.12
98.79%
96.80
77,473.08%
0.12
99.87%
197.30
-
dividend yield
ebit per revenue
-104.17
-
-13.19
87.33%
-1.58
88.05%
-50.88
3,126.47%
0.16
100.32%
-652.73
404,519.07%
0.41
100.06%
-1.54K
377,514.52%
-0.60
99.96%
ebt per ebit
1.04
-
1.00
3.09%
0.33
66.77%
1.03
208.99%
1.03
0.41%
1.44
39.20%
0.98
31.81%
1.02
3.47%
0.97
4.89%
0.68
29.91%
effective tax rate
0.01
-
-0.00
102.95%
-0.02
7,758.69%
-0.03
23.25%
-0.00
87.19%
0.01
297.91%
-0.00
134.92%
0.00
311.98%
0.00
89.86%
-0.02
3,935.17%
enterprise value multiple
-60.35
-
-11.54
80.88%
2.66
123.09%
-11.37
526.98%
-5.75
49.45%
51.81
1,001.24%
-26.04
150.26%
13.54
151.99%
-4.74
135.03%
-23.72
400.18%
fixed asset turnover
0.19
-
0.25
32.04%
2.17
785.26%
0.17
92.23%
3.98
2,254.63%
0.01
99.85%
2.93
50,030.94%
0.00
99.95%
1.21
88,816.91%
free cash flow per share
-0.16
-
1.99
1,315.81%
-4.76
339.23%
-1.94
59.13%
-2.06
6.13%
0.92
144.52%
-3.89
523.53%
6.02
254.67%
-6.85
213.85%
-3.44
49.85%
gross profit margin
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
-251.87
25,286.70%
0.65
100.26%
interest coverage
-238.23
-
-8.46
96.45%
14.37
-
inventory turnover
long term debt to capitalization
4.15
-
0.04
-
0.03
34.79%
0.08
179.01%
0.11
33.11%
0.11
2.37%
net income per ebt
0.99
-
1.00
0.95%
1.02
2.10%
1.03
0.49%
1.00
2.23%
0.99
1.00%
1.00
0.90%
1.00
0.72%
1.00
0.44%
1.02
1.97%
net profit margin
-104.57
-
-4.49
95.70%
-1.67
62.89%
-52.81
3,067.32%
0.23
100.44%
-642.48
278,383.69%
0.41
100.06%
-1.49K
360,637.92%
-0.42
99.97%
operating cash flow per share
-0.16
-
2.03
1,339.89%
-4.51
322.46%
-1.75
61.22%
-2.01
14.66%
1.04
151.93%
-3.61
446.87%
7.10
296.34%
-6.38
189.85%
-3.29
48.46%
operating cycle
197.30
-
operating profit margin
-104.17
-
-13.19
87.33%
-1.58
88.05%
-50.88
3,126.47%
0.16
100.32%
-652.73
404,519.07%
0.41
100.06%
-1.54K
377,514.52%
-0.60
99.96%
payables turnover
4.02
-
3.41
15.06%
pretax profit margin
-104.54
-
-4.40
95.79%
-1.62
63.07%
-52.63
3,139.59%
0.23
100.44%
-640.99
275,890.36%
0.42
100.06%
-1.49K
359,040.83%
-0.41
99.97%
price fair value
-58.00
-
-14.19
75.54%
1.07
107.52%
5.01
369.50%
3.49
30.22%
3.53
0.93%
6.07
72.06%
2.40
60.47%
1.69
29.75%
2.63
56.31%
receivables turnover
0.73
-
1.64
124.50%
15.61
854.43%
35.50
127.39%
2.93K
8,139.86%
3.77
99.87%
2.99K
79,291.16%
1.85
-
return on assets
-4.45
-
-0.16
96.36%
-0.07
58.48%
-0.25
274.55%
-0.34
33.92%
0.06
118.58%
-0.19
404.51%
0.14
171.91%
-0.29
311.21%
-0.07
76.23%
return on capital employed
10.71
-
-0.17
101.61%
-0.21
22.38%
-0.25
19.32%
-0.34
36.89%
0.05
113.43%
-0.20
541.61%
0.14
169.42%
-0.32
323.54%
-0.10
66.92%
return on equity
0.96
-
0.89
7.10%
-0.10
111.23%
-0.36
265.22%
-0.42
15.59%
0.07
116.92%
-0.21
394.55%
0.16
175.08%
-0.35
320.26%
-0.08
76.47%
total debt to capitalization
4.15
-
-0.35
108.42%
-0.31
11.91%
-0.10
67.83%
0.05
153.51%
0.04
32.79%
0.09
140.87%
0.12
34.28%
0.11
2.30%

All numbers in (except ratios and percentages)